NES
GSK icon

New England Securities’s GSK GSK Stock Holding History

New England Securities’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$225K Buy
4,202
+1,640
+64% +$91.8K 0.08% 247
2014
Q3 		$147K Buy
2,562
+556
+28% +$34.1K 0.05% 343
2014
Q2 		$134K Sell
2,006
-127
-6% -$8.6K 0.05% 377
2014
Q1 		$142K Buy
2,133
+488
+30% +$33K 0.05% 324
2013
Q4 		$110K Hold
1,645
– – 0.05% 379
2013
Q3 		$103K Buy
1,645
+724
+79% +$46.6K 0.05% 341
2013
Q2 		$58K Buy
+921
New +$58.5K 0.04% 394

Other funds holding GSK

LTI
Laffer Tengler Investments Nashville, Tennessee $677M AUM 27.58% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

New England Securities's GSK Position: Q4 2014 in Review

New England Securities increased its GSK (GSK) stake by 64% in Q4 2014, buying an estimated $91.8K and bringing the position to 4,202 shares worth $225K. The position accounts for 0.08% of the portfolio, ranked #247.

New England Securities first reported a position in GSK in Q2 2013 and has held it in 7 quarters since. 728 funds tracked by Wall St. Rank hold GSK as of Q4 2014.

  • New England Securities held 4,202 shares of GSK worth $225K as of Q4 2014.
  • New England Securities bought 1,640 GSK shares in Q4 2014, an estimated $91.8K.
  • GSK made up 0.08% of New England Securities's portfolio in Q4 2014, its #247 holding.
  • New England Securities first reported a position in GSK in Q2 2013 and has held it in 7 quarters since.
  • 728 funds tracked by Wall St. Rank held GSK as of Q4 2014.

Based on New England Securities's 13F filing for Q4 2014, filed 26 Jan 2015.